Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zai Lab (Shanghai) Co., Ltd.
This is a first-in-human, dose escalation trial of ZL-1201. The major aims of the study are to define the safety profile of this new drug, and to determine a recommended dose and schedule for potential additional trials.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically/cytologically confirmed, locally advanced unresectable or metastatic solid tumors and lymphomas that are refractory or intolerant to standard of care therapy, or for which no standard therapy exists.
